{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:56:25Z","timestamp":1791024985142,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Anusandhan National Research Foundation","doi-asserted-by":"publisher","award":["EEQ\/2022\/000950"],"award-info":[{"award-number":["EEQ\/2022\/000950"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejpb.2026.115231","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:29:33Z","timestamp":1788305373000},"page":"115231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rebamipide nanosuspension loaded in-situ gel: A promising strategy to improve ocular delivery and treatment of dry eye disease"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1327-0631","authenticated-orcid":false,"given":"Sayali","family":"Rathod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6612-2377","authenticated-orcid":false,"given":"Klaudi K.","family":"Vaiphei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8581-8948","authenticated-orcid":false,"given":"Akhila","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5905-0753","authenticated-orcid":false,"given":"Amoolya","family":"Sree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4260-6813","authenticated-orcid":false,"given":"Kendre Sandhya","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7864-6053","authenticated-orcid":false,"given":"Jayabalan","family":"Nirmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-3207","authenticated-orcid":false,"given":"Tamilvanan","family":"Shunmugaperumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0044-0984","authenticated-orcid":false,"given":"Sanjay K.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1411-2698","authenticated-orcid":false,"given":"Swatishree","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-8125","authenticated-orcid":false,"given":"Arvind","family":"Gulbake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejpb.2026.115231_b0005","article-title":"Epidemiology and Risk Factors of Dry Eye Disease","volume":"60","author":"Britten-Jones","year":"2024","journal-title":"Considerations for Clinical Management. Medicina (kaunas)"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115231_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ceo.12183","article-title":"Prevalence of dry eye syndrome in an adult population","volume":"42","author":"Hashemi","year":"2014","journal-title":"Clin Exp Ophthalmol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115231_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2014.08.021","article-title":"Prevalence of and risk factors associated with dry eye: the Korea National Health and Nutrition Examination Survey 2010-2011","volume":"158","author":"Ahn","year":"2014","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115231_b0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jtos.2020.07.016","article-title":"Association of dry eye disease and sun exposure in geographically diverse adult (\u226540 years) populations of India: The SEED (sun exposure, environment and dry eye disease) study - Second report of the ICMR-EYE SEE study group","volume":"18","author":"Tandon","year":"2020","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2026.115231_b0025","article-title":"Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease","volume":"75","author":"Qiao","year":"2022","journal-title":"J Drug Deliv Technol."},{"key":"10.1016\/j.ejpb.2026.115231_b0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2024.07.026","article-title":"Rosmarinic acid-grafted gelatin nanogels for efficient diquafosol delivery in dry eye disease therapy","volume":"373","author":"Zhou","year":"2024","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115231_b0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: Proceedings of the OCEAN group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejpb.2026.115231_b0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jconrel.2024.02.043","article-title":"Mucoadhesive liposomal delivery system synergizing anti-inflammation and anti-oxidation for enhanced treatment against dry eye disease","volume":"368","author":"Huang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115231_b0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijbiomac.2022.12.238","article-title":"Chondroitin sulfate and L-Cysteine conjugate modified cationic nanostructured lipid carriers: Pre-corneal retention, permeability, and related studies for dry eye treatment","volume":"228","author":"Zhu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115231_b0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5958\/2395-1451.2015.00025.6","article-title":"The role of Rebamipide ophthalmic suspension in management of dry eye disease","volume":"1","author":"Dorennavar","year":"2015","journal-title":"Indian J Clin Exp Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115231_b0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.25258\/ijddt.14.2.05","article-title":"Preparation and evaluation of rebamipide ophthalmic nanosuspension for dry eye therapy","volume":"14","author":"Reena","year":"2024","journal-title":"Int J Drug Deliv Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115231_b0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12886-023-03004-1","article-title":"Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial","volume":"23","author":"Eom","year":"2023","journal-title":"BMC Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115231_b0065","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4103\/IJO.IJO_2586_22","article-title":"Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre","volume":"71","author":"Jain","year":"2023","journal-title":"Indian J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115231_b0070","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","article-title":"Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study","volume":"119","author":"Kinoshita","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2026.115231_b0075","article-title":"A hyaluronic acid-modified cyclodextrin self-assembly system for the delivery of \u03b2-carotene in the treatment of dry eye disease","volume":"287","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115231_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119184","article-title":"Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution","volume":"578","author":"Wei","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115231_b0085","first-page":"3943","article-title":"A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: In vitro and in vivo evaluation","volume":"9","author":"Zhu","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejpb.2026.115231_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2020.07.001","article-title":"Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly water-soluble drugs","volume":"154","author":"Van Ngo","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115231_b0095","article-title":"QbD based formulation optimization of semi-solid lipid nanoparticles as nano-cosmeceuticals","volume":"66","author":"Amasya","year":"2021","journal-title":"J Drug Deliv Sci Technol."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115231_b0100","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/10837450.2019.1667384","article-title":"The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions","volume":"24","author":"Oktay","year":"2019","journal-title":"Pharm. Dev. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115231_b0105","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10717544.2014.923066","article-title":"Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study","volume":"23","author":"Gora","year":"2016","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115231_b0110","first-page":"428","article-title":"Development of cyclosporine a nanosuspension using an experimental design based on response surface methodology: In vitro evaluations.","volume":"21","author":"G\u00fclba\u011f P\u0131nar","year":"2024","journal-title":"Turk J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.ejpb.2026.115231_b0115","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1039\/D4NA00176A","article-title":"A poly-\u03b4-decalactone (PDL) based nanoemulgel for topical delivery of ketoconazole and eugenol against Candida albicans","volume":"6","author":"Dubey","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115231_b0120","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1080\/03639040701741810","article-title":"Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement","volume":"33","author":"Gao","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115231_b0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/03639045.2016.1239627","article-title":"Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form","volume":"43","author":"Xiong","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115231_b0130","article-title":"Unlocking the wound healing potential of Anastatica hierochuntica L. (Kaff Maryam) Extract's nanosuspension: UPLC-MS\/MS metabolic profiling, formulation development and statistical optimization","volume":"101","author":"Abdelhakeem","year":"2024","journal-title":"J Drug Deliv Sci Technol."},{"key":"10.1016\/j.ejpb.2026.115231_b0135","article-title":"Development and evaluation of nanocrystals loaded hydrogel for topical application","volume":"74","author":"Kumar","year":"2022","journal-title":"J Drug Deliv Sci Technol."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115231_b0140","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1007\/s13346-022-01155-0","article-title":"Gellan gum\u2013based in situ gelling ophthalmic nanosuspension of Posaconazole","volume":"12","author":"Khare","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115231_b0145","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-010-9413-0","article-title":"In situ gelling gelrite\/alginate formulations as vehicles for ophthalmic drug delivery","volume":"11","author":"Liu","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115231_b0150","article-title":"Nano-dimensional in-situ hydrogels of lifitegrast: an advancement in preservation time, sustained release and corneal healing in dry eye syndrome","volume":"89","author":"Bhatt","year":"2023","journal-title":"J Drug Deliv Sci Technol."},{"key":"10.1016\/j.ejpb.2026.115231_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118734","article-title":"Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time","volume":"574","author":"Destruel","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115231_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118979","article-title":"Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatment","volume":"576","author":"Juri\u0161i\u0107 Dukovski","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115231_b0165","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3109\/10717544.2014.987333","article-title":"Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel","volume":"23","author":"Kesarla","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115231_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114208","article-title":"Combination of self-assembling system and N,O-carboxymethyl chitosan improves ocular residence of anti-glaucoma drug","volume":"197","author":"Kailasam","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115231_b0175","article-title":"Gellan gum and sodium alginate in-situ gel of monocaprin for effective corneal permeation","volume":"4","author":"Giri","year":"2023","journal-title":"Food Hydrocoll Hlth."},{"key":"10.1016\/j.ejpb.2026.115231_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3964642","article-title":"Evaluating the functionality of conjunctiva using a rabbit dry eye model","volume":"2016","author":"Ning","year":"2016","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2026.115231_b0185","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biopha.2017.10.032","article-title":"A mouse dry eye model induced by topical administration of the air pollutant particulate matter 10","volume":"96","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115231_b0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsps.2018.07.018","article-title":"Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity","volume":"27","author":"Ibrahim","year":"2019","journal-title":"Saudi Pharm J."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115231_b0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/pharmaceutics18050521","article-title":"In silico preformulation modeling, solubility enhancement, and sustainable release of rebamipide utilizing deep eutectic mixture loaded bioadhesive controlled release granules for gastritis treatment","volume":"18","author":"Almajidi","year":"2026","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115231_b0200","first-page":"1270","article-title":"Development and validation of a new UV method for the analysis of rebamipide","volume":"3","author":"Srivastava","year":"2011","journal-title":"Int J Pharmtech Res."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115231_b0205","first-page":"527","article-title":"Microwave radiation induced synthesis of hydroxypropyl methylcellulose-graft- (polyvinylalcohal-co-acrylic acid) polymeric network and its in vitro evaluation","volume":"74","author":"Iqbal","year":"2017","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115231_b0210","article-title":"Treatment of endophthalmitis using a novel methacrylic anhydride-modified hydroxypropyl methylcellulose hydrogels loaded with S-nitrosoglutathione: An ex-vivo keratitis model","volume":"100","author":"Chang","year":"2024","journal-title":"J Drug Deliv Sci Technol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115231_b0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1208\/s12249-024-02871-1","article-title":"Design of experiments-driven optimization of spray drying for amorphous clotrimazole nanosuspension","volume":"25","author":"Gajera","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115231_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126279","article-title":"Ion-activated gellan gum in situ gel for prolonged ocular administration of tofacitinib citrate: An innovative treatment approach for dry eye disease","volume":"685","author":"Chen","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115231_b0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/01932690701688482","article-title":"Gelrite\u2010based in vitro gelation ophthalmic drug delivery system of gatifloxacin","volume":"29","author":"Kalam","year":"2008","journal-title":"J. Dispers. Sci. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115231_b0230","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archopht.1981.03930010303017","article-title":"Normal human tear pH by direct measurement","volume":"99","author":"Abelson","year":"1981","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115231_b0235","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1021\/acs.molpharmaceut.4c00554","article-title":"From Preformulative Design to In Vivo Tests: A complex path of requisites and studies for nanoparticle ocular application. Part 1: Design, characterization, and preliminary in vitro studies","volume":"21","author":"Cimino","year":"2024","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115231_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052434","article-title":"Artificial tears: Biological role of their ingredients in the management of dry eye disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115231_b0245","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu Y, Xie J, Zheng Q, Yue P, Chen L, et al. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine. Int J Nanomedicine. 2020;15:10435-51.","DOI":"10.2147\/IJN.S265659"},{"key":"10.1016\/j.ejpb.2026.115231_b0250","doi-asserted-by":"crossref","unstructured":"Alsaidan OA, Zafar A, Yasir M, Alzarea SI, Alqinyah M, Khalid M. Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study. Gels. 2022;8(11).","DOI":"10.3390\/gels8110687"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115231_b0255","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s42269-023-01123-9","article-title":"Revolutionizing ocular drug delivery: Recent advancements in in situ gel technology","volume":"47","author":"Paul","year":"2023","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.ejpb.2026.115231_b0260","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.1038\/srep11337","article-title":"Chitosan grafted methoxy poly(ethylene glycol)-poly(\u03b5-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac","volume":"5","author":"Shi","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115231_b0265","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/15376516.2021.1941461","article-title":"Studying the ophthalmic toxicity potential of developed ketoconazole loaded nanoemulsion in situ gel formulation for ophthalmic administration","volume":"31","author":"Tavakoli","year":"2021","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.ejpb.2026.115231_b0270","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.2147\/DDDT.S309648","article-title":"Topical delivery of levocarnitine to the cornea and anterior eye by thermosensitive in-situ gel for dry eye disease","volume":"15","author":"Ma","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejpb.2026.115231_b0275","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2147\/OPTH.S351898","article-title":"A practical approach to severity classification and treatment of dry eye disease: A proposal from the mexican dry eye disease expert panel","volume":"16","author":"Rodriguez-Garcia","year":"2022","journal-title":"Clin. Ophthalmol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:47:34Z","timestamp":1791024454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":55,"alternative-id":["S0939641126002523"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115231","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebamipide nanosuspension loaded in-situ gel: A promising strategy to improve ocular delivery and treatment of dry eye disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115231"}}